
![Trilaciclib Intermediate 1 (2-(methylthio)-4-(3-oxo-1,4-diazaspiro[5.5]undec-1-yl)-5-Pyrimidinecarboxylic acid ethyl ester)](/_next/image?url=https%3A%2F%2Fcdn.scimplify.com%2Fproducts%2Fimages%2F69b698d466ea274e8c4f42fb%2F1a5703ff-bdad-45f7-b884-435bb84f6481.png&w=3840&q=75)
CAS Number: 2170746-95-7
Molecular Formula: C17H24N4O3S
Purity: (HPLC) ≥ 98% or ≥ 99%
Our Trilaciclib API intermediate portfolio offers high-performance building blocks for the synthesis of the first-in-class, FDA-approved CDK4/6 inhibitor designed to protect bone marrow during chemotherapy. Trilaciclib (a kinase inhibitor used to reduce chemotherapy-induced myelosuppression) requires high-purity buildi...

Category : Pharmaceutical Actives & Precursors
Sub-Category : Active Pharmaceutical Ingredients (APIs)
Description : Calcium acetate monohydrate (CAS No: 5743-26-0) occupies a critical position in the global specialit...
Category : Pharmaceutical Actives & Precursors
Sub-Category : Intermediates & Precursors
Category : Pharmaceutical Actives & Precursors
Sub-Category : Intermediates & Precursors
Description : P-Nitrobenzoyl Chloride (CAS 122-04-3) is a critical building block in the API intermediates market,...